Estrogen Receptor Positive Breast Cancer Recruiting Phase 2 Trials for Tamoxifen (DB00675)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02668666Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast CancerTreatment